Reuters logo
BRIEF-Juniper Pharmaceuticals reports Q1 loss per share $0.13
May 4, 2017 / 11:55 AM / in 6 months

BRIEF-Juniper Pharmaceuticals reports Q1 loss per share $0.13

May 4 (Reuters) - Juniper Pharmaceuticals Inc:

* Juniper pharmaceuticals reports first quarter 2017 financial and operating results

* Q1 loss per share $0.13

* Q1 revenue $11.2 million

* Frank Condella will not seek re-election to co’s board of directors

* Juniper Pharmaceuticals Inc - expect to be in a position to file up to three ind’s with U.S. Food and drug administration in first half of 2018

* Q1 earnings per share view $-0.09, revenue view $11.3 million -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below